1. Home
  2. /
  3. Politics
  4. /
  5. DOD Memo Reveals Special...

DOD Memo Reveals Special Treatment: Transgender Soldiers on Hormone Therapy Can Skip Deployments

A Department of Defense (DOD) memo obtained by The Dossier sheds light on special treatment for transgender soldiers receiving hormone therapy. According to the memo, these soldiers may avoid deployment for up to 300 days while undergoing treatment at the Womack Army Medical Center (WAMC) at Fort Liberty. The memo also outlines other treatments and surgeries, including “upper” and “bottom” surgeries, available to transgender troops at taxpayers’ expense. This revelation has sparked concerns and debates regarding the prioritization of transgender soldiers’ needs within the military.

Read More: These Celebrities Have Publicly Criticized Donald Trump!

Extended Stabilization Period: Delaying Deployments

Credit: DepositPhotos

The DOD memo states that most transgender service members receiving cross-sex hormone therapy will require up to 300 days to be clinically stabilized. During this time, they will remain in a non-deployable status. This extended stabilization period raises questions about the impact on military readiness and whether the needs of transgender soldiers take precedence over mission requirements.

Treatment Options and Surgeries

According to the memo, after 12 months of hormone therapy, transgender service members can request “upper” and “bottom” surgeries. Surgeries such as “upper” surgery are covered benefits and can be performed at WAMC. However, surgeries like “bottom” surgery and “voice feminization” surgery are not covered. The memo also mentions the availability of facial/body contouring and laser hair removal, with differing considerations for cosmetic and medically necessary procedures.

Read Also: These Celebrities All Support Trump

Exception to Policy: Uniform and Facilities

During the gender transition period, which can take 9-18 months, transgender service members can request exceptions to policy regarding uniform, grooming, fitness testing, billeting, and bathroom and shower facilities. This provision aims to align with the service members’ self-identified gender. The memo highlights the importance of unit commanders’ involvement in approving the medical treatment timeline while minimizing readiness impact.

Implications and Controversy

The DOD memo comes as a result of the Biden Administration’s policy allowing transgender individuals to serve in the military. While the policy reversal has been hailed as progress for inclusivity, it has raised concerns about potential readiness implications and the allocation of resources. Critics argue that prioritizing the needs of transgender soldiers may come at the expense of overall military effectiveness.

Looking Ahead: Evolving Policies and Readiness Considerations

As the DOD implements policies accommodating transgender service members, questions regarding the balance between inclusivity and military readiness persist. The extended stabilization period and access to various surgeries raise important considerations about the impact on deployment schedules and the overall preparedness of the armed forces. Ongoing dialogue and evaluation are crucial in ensuring that policies and treatments align with the needs of both transgender soldiers and the military as a whole.

Engage Further

What are your thoughts on the DOD’s approach to transgender soldiers receiving hormone therapy? Do you believe it strikes the right balance between inclusivity and military readiness? Share your opinions and join the conversation. Let’s explore the impact of these policies on our armed forces and discuss their implications for national defense.

Read Next: 10 Things You Probably Didn’t Know About Tucker Carlson

mm

Malik is a skilled writer with a passion for news and current events. With their keen eye for detail, they provide insightful perspectives on the latest happenings. Stay informed and engaged!